Hansa Medical trades up after €66m block
In an otherwise barren week for block trades, Hansa Medical, the Swedish biotechnology company, raised Skr399.8m of fresh capital to fund product development. The deal also provided an opportunity for Nexttobe AB to sell a portion of its stake in the company.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: